This double-blind, prospective, randomized, controlled trial examined the effects of thoracic epidural block and intravenous clonidine and opioid treatment on the postoperative Th1/Th2 cytokine ratio after lung surgery. The primary endpoint was the interferon g (IFN-g; Th1 cytokine)/interleukin 4 (IL-4; Th2 cytokine) ratio. Secondary endpoints were reductions in pain and incidence of pneumonia. METHODS: Sixty patients were randomized into three groups to receive remifentanil intravenously (remifentanil group, n = 20), remifentanil and clonidine intravenously (clonidine group, n = 20), or ropivacaine epidurally (ropivacaine group, n = 20). Pain was assessed using a numerical rating scale (NRS). Cytokines were measured using a cytometric bead array. RESULTS: Patients in the ropivacaine group (thoracic epidural block) had a significantly lower IFN-g/IL-4 ratio at the end of surgery than those in the remifentanil group and clonidine group. There were no significant between-group differences in the IFN-g/IL-4 ratio at other time-points. There were no differences in NRS scores at any timepoint. No patient developed pneumonia. CONCLUSION: Intraoperative thoracic epidural block decreased the IFN-g/IL-4 ratio immediately after lung surgery, indicating less inflammatory stimulation during surgery.
Introduction
The human immune system responds to major surgery and anaesthesia with an immediate acute-phase reaction 1,2 characterized by increases in T helper type 1 (Th1) proinflammatory cytokines and mediators such as tumour necrosis factor α (TNF-α) and interferon γ (IFN-γ). 3 -6 This reaction is known to correlate with the magnitude of trauma. 7 -15 Hyperinflammation is followed by a compensatory response, with elevated plasma concentrations of Th2 anti-inflammatory cytokines such as interleukin (IL)-4, IL-5 and Neurogenic blockade and perioperative immune reactivity . 16 -21 This response may have evolved to protect the injured host from the harmful effects of injury-induced inflammation, but the downregulation of proinflammatory mediators can result in cytokine imbalance and clinical immunosuppression. 7,22 -27 Increased serum IL-10 concentrations have been shown to correlate significantly with infection, postoperative outcome, sepsis and multiple organ failure. 4,17,18,24,27 -34 The incidence of pneumonia after lung resection ranges from 2% to 20%. 35 -44 More than 60% of pneumonia cases have an early onset, occurring in the first 3 days after operation. 39, 45 Postoperative pneumonia after pulmonary surgery increases the inhospital mortality rate to 14 -26%, 39, 40, 45 compared with 1 -6% in patients without pneumonia. 35,36,38 -40,46,47 Lung resection is most frequently carried out as treatment for lung cancer. 47 The World Health Organization (WHO) has reported that lung cancer mortality accounts for 1.3 million deaths per year. 48 Lung cancer is the leading cause of cancer death worldwide and has become the second most frequent cause of death (after cardiovascular disease) in the USA and Germany. 49, 50 In spite of advances in surgical technique, few attempts have been made specifically to protect the immune system of patients undergoing lung resection.
Thoracic epidural block is known to reduce postoperative mortality and morbidity 51 -55 and mitigates the postoperative immunological impairment described above. 56 -62 Epidural analgesia also reduces postoperative inflammation 60, 63 and postoperative pain. 64, 65 Thoracic epidural block has been found to be a significant protective factor in reducing nosocomial infections after lung surgery. 38 α 2 -Adrenergic receptor agonists, such as clonidine, reduce anaesthetic requirements, attenuate sympathoadrenal responses during surgery and reduce plasma noradrenaline concentrations by stimulation of presynaptic α 2 -adrenoceptors. 66, 67 Perioperative treatment with clonidine inhibits the hypothalamic-pituitary-adrenal axis 68 and causes a postoperative shift towards a Th2 cytokine response. 69 -71 Opioids impair the immune system; 72,73 on the other hand, morphine is known to protect from stress by inhibiting the hypothalamic-pituitary-adrenal axis. 2, 74 Opioids exert their effects on the immune system by modulating the cytokine response through opioid receptors either on immune cells or within the central nervous system. 75 -78 The primary outcome measure of the current trial was the Th1/Th2 cytokine balance, i.e. the IFN-γ/IL-4 ratio, after perioperative neurogenic blockade of opioid receptors or local and systemic sympathicolysis with clonidine or thoracic epidural block. The secondary outcome measures were postoperative pain and the incidence of pneumonia. 
Patients and methods

STUDY DESIGN AND REGISTRATION
PATIENT SELECTION AND RANDOMIZATION
Consecutive patients scheduled for elective lung surgery at the Department of General, Visceral, Vascular and Thoracic Surgery of our hospital (Charité-University Hospital Berlin, Berlin, Germany) between January 2006 and May 2007 were screened for eligibility. Patients meeting at least one of the following criteria were excluded from the study: (i) < 18 years old; (ii) guardianship/conservatorship (people who were in a coma, had advanced Alzheimer's disease or had other serious illnesses or injuries); (iii) refusal to participate; (iv) preexisting alterations of the immune system (such as infections meeting the criteria of the US Centers for Disease Control [CDC] 79 ) or undergoing treatments or having disorders with direct influence on the immune system (including immunomodulating therapy or adrenal pathology); (v) pregnancy; (vi) contraindications for epidural catheter insertion; (vii) contraindications for clonidine, ropivacaine or remifentanil treatment; (viii) previous treatment with trial drugs or drugs belonging to the same pharmacological group; (ix) class III or higher heart failure according to The New York Heart Association Functional Classification; 80 and (x) myocardial infarction in the 8 weeks before surgery.
A flow chart showing the process of selection and randomization of the participants to the three treatment groups (remifentanil group, clonidine group and ropivacaine group), according to the Consolidated Standards of Reporting Trials (CONSORT) guidelines, 81 is shown in Fig. 1 .
STUDY PROTOCOL AND MEASUREMENTS
Patients received remifentanil intravenously (remifentanil group), remifentanil and clonidine intravenously (clonidine group) or ropivacaine epidurally (ropivacaine group) in a double-blinded manner. Independent pharmacists assigned the patients to the different groups according to a computergenerated randomization list based on block randomization (six patients/block) and supplied trial drugs and placebo in coded syringes of identical appearance, as shown in Table 1 . All study personnel and participants were blinded to treatment assignment for the duration of the study, and were not informed about block sizes.
After oral premedication with 0.1 mg/kg midazolam, all patients received epidural catheterization independently of randomization. Local infiltration of 2 -5 ml 1% lidocaine by thoracic epidural puncture was performed in the operating room using a median approach with the loss of resistance technique at the level of Th4 -Th7. Accidental subdural catheterization was ruled out by injecting a test dose of 3 ml bupivacaine 0.5% after insertion of the catheter 5 cm into the epidural space. All lung resections were performed by a lung surgery specialist assisted by at least one senior surgeon. Lung resection was performed using either a lateral thoracotomy approach or by video-assisted thoracic surgery, depending on the malignancy and localization of the lung disease. 82, 83 Anaesthesia was performed according to a standard protocol by a team of anaesthetists under the supervision of a Neurogenic blockade and perioperative immune reactivity highly experienced thoracic anaesthesia specialist. 84 Administration of investigational drugs began after epidural catheterization and a schematic representation of the trial intervention is shown in Fig. 2 . Postoperative analgesia was performed in all patients with thoracic epidural block using 6 -12 ml/h ropivacaine 0.2% and 0.5 µg/ml sufentanil according to standard protocol. 84 Blood samples were collected in sterile ethylenediaminetetraacetic acid tubes prior to epidural Patients excluded after inclusion n = 10
Did not meet inclusion criteria n = 37
Pre-existing alteration of the immune system, n = 20 (pneumonia, n = 6; cortisol therapy, n = 5; interferon therapy, n = 2; aspergillosis, n = 2; surrenal adenoma, n = 1; pleural empyema, n = 1; chemotherapy, n = 1; immunosuppression therapy, n = 1; granulomatosis, n = 1) Resurgery in patients already enrolled in the study, n = 8 Contraindications for epidural catheter insertion, n = 4 Pre-existing treatment with opioids, n = 3 Guardianship/conservatorship, n = 2 Futile epidural catheterization, n = 2 New onset contraindication for epidural catheterization, n = 2 Technical/logistical problem, n = 2 Discontinuation of surgery, n = 1 Preoperative treatment with opioids necessary, n = 1 Revocation of consent, n = 1 Cardiac arrest/unblinding, n = 1 Neurogenic blockade and perioperative immune reactivity catheterization at baseline, at retrieval of resected lung tissue, within the first postoperative hour, and at morning rounds on the first, second and third postoperative days. Infections were assessed according to CDC criteria 79 at the same times as blood withdrawal. Pain intensity was assessed using a numerical rating scale 85 (NRS; ranging from 0 [no pain] to 10 [the most intense pain possible]) at rest and during coughing. The NRS scores were assessed immediately after surgery and on the first, second and third postoperative days.
CYTOKINE ASSAYS
Blood samples were collected as described above and immediately transferred to the laboratory for analysis. For the analysis of ex vivo T-cell cytokine secretion, 200 µl whole blood was incubated (37°C, 5% carbon dioxide) with 700 µl of RPMI 1640 (Biochrom, Berlin, Germany) and 100 µl of a solution of 1 mg/ml concanavalin A (Sigma-Aldrich, St Louis, MO, USA). After 24 h of incubation the culture supernatant was removed and stored at −70°C until determination of IFN-γ and IL-4 using the BD™ Cytometric Bead Array assay (BD Biosciences, Heidelberg, Germany), according to the manufacturer's instructions. The interassay coefficient of variance of this assay is < 10% for each analyte.
STATISTICAL ANALYSES
Descriptive statistics were computed for all study variables. Discrete variables are expressed as number (%) and continuous variables as mean ± SD or median (25th -75th percentiles). Because of the small sample sizes, between-group differences in clinical parameters of interest were tested using nonparametric statistical tests Changes in the clinical outcomes of interest with respect to time were analysed by nonparametric multivariate analysis of covariance (MANCOVA) for repeated measurements in a two-factorial design (first factor, treatments; second factor, repetitions in time) with the baseline as covariate. 86 All time points were compared simultaneously on the corresponding response curves. After global testing, post hoc analyses for baselinecorrected differences between the three treatment groups at time-points of interest were performed using the Kruskal-Wallis test and (for significant results) the Mann-Whitney U-test between pairs of groups. All tests constituted exploratory data analysis, and no adjustments for multiple testing were made.
Statistical calculations were performed with SPSS ® version 16.0 (SPSS Inc., Chicago, IL, USA) for Windows ® and SAS ® version 9.2 (SAS Institute, Cary, NC, USA). A value of P < 0.05 was considered to be statistically significant.
The investigation was planned as a pilot study with 20 patients per group, because of Surgery Neurogenic blockade and perioperative immune reactivity unknown differences between the groups with respect to Th1/Th2 cytokine ratios. In general, no power calculation is required in advance for pilot studies. A retrospective power calculation was performed at the end of the study for the end of surgery timepoint.
Results
A total of 113 consecutive patients scheduled for elective lung surgery were screened for inclusion in the study and 60 patients met the study's criteria and were randomized into the three treatment groups, as shown in Fig.  1 . There were no statistically significant between-group differences in any demographic, clinical or haemodynamic characteristics (Tables 2 and 3 ). Lateral thoracotomy was performed in 76% of patients and video-assisted thoracic surgery was performed in 24%.
The MANCOVA analysis revealed a statistically significant difference between the three groups in the IFN-γ/IL-4 ratio (Th1/Th2 cytokine ratio) adjusted for baseline (P = 0.012). Post hoc analysis with the Kruskal-Wallis test showed that the ratio (baselinecorrected) differed significantly between the three treatment groups at the end of surgery (P = 0.010). Mann-Whitney U-tests on data at that time-point found no significant difference between the remifentanil and the clonidine groups, but a significantly lower ratio in the ropivacaine group compared with both the remifentanil group (P = 0.004) and the clonidine group (P = 0.019; Fig. 3) .
None of the patients developed earlyonset pneumonia and there were no between-group differences in any clinical endpoint ( Table 4 ).
Perioperative pain intensity was assessed using the NRS at rest and during coughing. The NRS scores immediately after surgery were lower in the ropivacaine group than in the remifentanil and clonidine groups, but the differences did not reach statistical significance (Figs 4 and 5 ). There were no significant differences between the remifentanil and clonidine groups. There were no statistically significant betweengroup differences in NRS scores at any subsequent time-point. VATS, video-assisted thoracoscopic surgery; OLV, one-lung ventilation; SBP, systolic blood pressure; DBP, diastolic blood pressure. a Difference between maximum and minimum heart rate. Neurogenic blockade and perioperative immune reactivity 
Discussion
The most important finding of this study was the significantly lower Th1/Th2 cytokine ratio at the end of surgery in the ropivacaine group compared with the remifentanil group and the clonidine group. A previous doubleblind, prospective, randomized, controlled trial in patients undergoing laparoscopic radical hysterectomy revealed reduced elevation of proinflammatory cytokines in the epidural block group (epidural morphine and lidocaine) compared with the control group (epidural normal saline). 87 In the present study 76% of patients underwent thoracotomy and, therefore, the attenuated proinflammatory cytokine response cannot be related to a less invasive surgical approach alone. These results are consistent with those of other studies comparing pre-emptive with postoperative epidural analgesia, which reported an attenuated postoperative proinflammatory cytokine response after transabdominal hysterectomy 64 and abdominal surgery if epidural block was performed before surgery. 60 General anaesthesia is well known to impair the immune system. 1 In contrast to the present study, spinal anaesthesia has been shown to result in an increased Th1/Th2 cytokine ratio compared with general anaesthesia for transurethral resection of the prostate. 59 The study by Le Cras et al., 59 included patients receiving spinal but not epidural block, complicating comparisons with the present study. In a study by Yokoyama et al., 88 thoracic epidural block was unable to suppress inflammation FIGURE 4: Box and whisker plots of numerical pain rating scale (NRS) scores at rest immediately after surgery for patients who received remifentanil, clonidine or ropivacaine during lung resection surgery (n = 20 per group). The heavy band represents the median (50th percentile), the box shows the 25th and 75th percentiles, the ends of the whiskers represent the lowest and highest extremes of the data within 1.5 times of the interquartile range and the circle represents an outlier. There were no statistically significant between-group differences in NRS scores 
Remifentanil
Clonidine Ropivacaine Neurogenic blockade and perioperative immune reactivity after radical oesophagectomy. All patients in that study, 88 however, were mechanically ventilated at least until the morning of the first postoperative day, a considerable difference from the present study in which immediate extubation was the target. In the present study, Th1/Th2 cytokine ratios in the clonidine group were not significantly lower than those in the remifentanil group at any time-point, in contrast to the only previous study on this subject. 71 This divergence could be due to differences in study design, since patients in the study by von Dossow et al. 71 were on cardiopulmonary bypass, which is known to lead to postoperative immune alteration. 29, 30 Patients receiving intraoperative thoracic epidural block (ropivacaine group) had lower NRS scores immediately after surgery, but this effect did not reach statistical significance. These reduced NRS scores are in accordance with previous studies that have revealed lower pain levels with thoracic epidural block. 54, 64, 65 Tissue and peripheral nerve injury leads to a local inflammatory reaction accompanied by increased levels of proinflammatory cytokines, which induce peripheral and central nervous system sensitization, resulting in hyperalgesia. 89 The reduced inflammatory response immediately after surgery in the present study suggests that better control of immune reactivity might result in less postoperative pain in patients receiving thoracic epidural block. For ethical reasons, all patients in the present study were treated using the same postoperative analgesia strategy (i.e. thoracic epidural FIGURE 5: Box and whisker plots of numerical pain rating scale (NRS) scores during coughing immediately after surgery for patients who received remifentanil, clonidine or ropivacaine during lung resection surgery (n = 20 per group). The heavy band represents the median (50th percentile), the box shows the 25th and 75th percentiles, the ends of the whiskers represent the lowest and highest extremes of the data within 1.5 times of the interquartile range and the circles represent outliers. There were no statistically significant between-group differences in NRS scores 
Clonidine Ropivacaine Neurogenic blockade and perioperative immune reactivity block) and it was, therefore, not possible to assess any significant outcomes in followup. These findings are in accordance with previous studies that have reported no early pre-emptive analgesic effect in major surgery. 90 No cases of early-onset pneumonia were observed in the present study. There is some evidence that epidural analgesia protects against pneumonia after thoracic surgery, 52 -54 and postoperative thoracic epidural block is known to reduce morbidity and mortality. 38,51,53 -55 In the present study, however, there was no benefit with regard to pneumonia, pneumothorax, repeat surgery, blood transfusion, admission to the intensive care unit (ICU), length of ICU stay, readmission to the ICU, length of hospital stay or mortality rate. Previous studies have reported an improved outcome in patients treated with postoperative thoracic epidural block, 51, 53 but ethical considerations prohibited the withholding of postoperative thoracic epidural block from any patient in the present study. It was expected, however, that there would be no significant betweengroup differences in clinical outcome so the present study focused on the immune reaction during and immediately after surgery in order to characterize the influence of neurogenic blockade on the immune system. The well-implemented use in the study hospital of standard operating procedures 91 and fast-track surgery 92, 93 (with the aim of reducing morbidity and mortality) could represent potential selection bias in the current trial. There was no significant between-group difference in length of hospital stay, a finding consistent with previous trend-setting studies. 47, 94, 95 The newest data from the Society of Thoracic Surgeons show a median length of stay of 5 days, considerably shorter than that in the present study. 44 The present study had several limitations. The identical postoperative management strategy across all three groups meant that outcome measures regarding pneumonia, length of stay and mortality were not assessed. This postoperative strategy was chosen because postoperative thoracic epidural block decreases the incidence of postoperative pneumonia. 52 -54 For ethical reasons, therefore, it was not possible to withhold this treatment. The second limitation was the pilot study design although, when comparing the Th1/Th2 cytokine ratios of the ropivacaine group with those in the remifentanil and clonidine groups at the end of surgery, the sample sizes assured sufficient power (85% for remifentanil and 60% for clonidine versus ropivacaine, α = 5% two-sided).
In conclusion, intraoperative thoracic epidural block decreased the IFN-γ/IL-4 ratio immediately after surgery, indicating less inflammatory stimulation during surgery. Postoperative analgesia with thoracic epidural block using ropivacaine and sufentanil was performed in all groups. This strategy resulted in similar postoperative pain levels among the groups and may have prevented early-onset pneumonia in this limited patient population.
